Evidence map›Paper›PMID 40692709›Full record

ArticleFrontiers in genetics2025

Geometry-enhanced graph neural networks accelerate circRNA therapeutic target discovery.

Zhen Li, Mingming Qi, Juyuan Huang, Wei Zhang, Xu Tan, Yifan Chen

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhen LiSchool of Artificial Intelligence, Shenzhen Institute of Information Technology, Shenzhen, China.
Mingming QiSchool of Data Science and Artificial Intelligence, Wenzhou University of Technology, Wenzhou, China.
Juyuan HuangDepartment of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wei ZhangDepartment of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xu TanSchool of Artificial Intelligence, Shenzhen Institute of Information Technology, Shenzhen, China.
Yifan ChenSchool of Information Engineering, Changsha Medical University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) play pivotal roles in various biological processes and disease progression, particularly in modulating drug responses and resistance mechanisms. Accurate prediction of circRNA-drug associations (CDAs) is essential for biomarker discovery and the advancement of therapeutic strategies. Although several computational approaches have been proposed for identifying novel circRNA therapeutic targets, their performance is often limited by inadequate modeling of higher-order geometric information within circRNA-drug interaction networks. To overcome these challenges, we propose G2CDA, a geometric graph representation learning framework specifically designed to enhance the identification of CDAs and facilitate therapeutic target discovery. G2CDA introduces torsion-based geometric encoding into the message propagation process of the circRNA-drug network. For each potential association, we construct local simplicial complexes, extract their geometric features, and integrate these features as adaptive weights during message propagation and aggregation. This design promotes a richer understanding of local topological structures, thereby improving the robustness and expressiveness of learned circRNA and drug representations. Extensive benchmark evaluations on public datasets demonstrate that G2CDA outperforms state-of-the-art CDA prediction models, particularly in identifying novel associations. Case studies further confirm its effectiveness by uncovering potential drug interactions with the ALDH3A2 and ANXA2 biomarkers. Collectively, G2CDA provides a robust and interpretable framework for accelerating circRNA-based therapeutic target discovery and streamlining drug development pipelines. Our code are archived in: https://github.com/lizhen5000/G2CDA.

Indexed as

biomarker discoverycircRNA-drug networkcircRNA therapeutic targetsdrug developmentgeometric graph representation

Identifiers

PMID40692709
PMCPMC12277138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.